SCHEMBL23043040

SCHEMBL23043040

CC1(C)O[C@@H]2[C@H](O1)[C@@H](CO)O[C@H]2c1cnc2c(NC(=O)OCc3ccccc3)ncnn12

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 2/20 0.37
▸ PDE1B Q01064 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ EGFR P00533 1/20 0.34
▸ ERBB2 P04626 1/20 0.34
▸ TSHR P16473 2/20 0.33
▸ FSHR P23945 2/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ ADORA2A P29274 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ SLC29A1 Q99808 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23042877 0.89 PDE1B (0.33) PDE1BNPC1RAB9AEGFRERBB2
SCHEMBL23043039 0.78 PI4KA (0.34) ADORA3POLBALDH1A1
SCHEMBL15607006 0.76 ADORA3 (0.50) ADORA3ADORA1ADORA2A
SCHEMBL26832567 0.75 TMPRSS2 (0.37) MAPK1
SCHEMBL15605871 0.75 PI4KA (0.49) ADORA3ADORA1SMN1; SMN2MAPK1ALDH1A1
SCHEMBL16698763 0.74 TMPRSS2 (0.40) ADORA3ALDH1A1TDP1
SCHEMBL16710860 0.73 TMPRSS2 (0.38) —
SCHEMBL23042853 0.73 ADORA3 (0.36) ADORA3NPC1RAB9ATSHRADORA1
SCHEMBL25495987 0.69 TMPRSS2 (0.41) ADORA3ADORA1SMN1; SMN2ALDH1A1ADORA2A
SCHEMBL15607008 0.69 ADORA3 (0.43) ADORA3TSHRADORA1MAPK1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021040356-A1 C-NUCLEOSIDES, C-NUCLEOTIDES AND THEIR ANALOGS, EQUIVALENTS AND PRODRUGS THEREOF FOR ECTONUCLEOTIDASE INHIBITION KAINOS MEDICINE, INC. (KR) 2021-03-04 — — WO disclosed
Send feedback